Fred Hutch is at the forefront of a fundamental shift in the way cancer is treated and cured. Our researchers are developing new ways to empower a patient’s own immune system to do what it does ...

Fred Hutch scientists are producing some of the most important breakthroughs in the prevention, early detection and treatment of cancer, HIV and other diseases. Our scientists study every aspect of ...

At Fred Hutch, we bring the same level of commitment and integrity to our patients, donors and investors that we do to our clinical care and scientific research. We take our responsibility seriously, ...

The clinical researchers at Fred Hutch relentlessly pursue the best outcomes for our patients. We continually develop innovative, experimental therapies and seek approaches to improve cancer treatment ...

Zinc’s immune-boosting properties are well-established, but we’re still untangling how it works. In a new study published in late March in the scientific journal Blood, Fred Hutchinson Cancer Research ...

An international team of researchers co-led by Fred Hutchinson Cancer Center’s genetic epidemiologist Ulrike (Riki) Peters, PhD, has pinpointed what’s likely driving many colorectal cancers in people ...

AWS, Deloitte, Microsoft and NVIDIA bring the latest in AI technology, coordination, and compute to the alliance and back with initial funding SEATTLE – Oct. 2, 2024 – Four National Cancer ...

Fred Hutch virologists eliminated at least 90% of HSV-1 in preclinical models of oral and genital herpes and reduced viral shedding in a study published in Nature Communications SEATTLE — May 13, 2024 ...

Early in 2020, Dr. Paul M. Buckley stepped into the newly created role of administrative director of Fred Hutchinson Cancer Research Center’s new Office of Diversity, Equity and Inclusion. With ...

Editor's note: This is the first of a two-part series on cancer and depression. Part two will focus on a new screening tool to help identify patients at risk. When Ruth Kaminski learned that the “spot ...

Some patients become advocates because everything went right: the diagnosis was made early, the surgery went well, the cancer-driving mutation was found and communicated to other family members, ...

The first large observational study of nearly 1,000 cancer patients who contracted COVID-19 was published today by The Lancet and simultaneously announced at a virtual ASCO 2020, the large annual ...